Ceepax Pharma Private Limited - Company Profile

It is a pharma private limited company based in Jabalpur, Madhya Pradesh, India, established in 2019.
2019 Jabalpur, Madhya Pradesh, India Active
Last Updated:
Access Report
About Ceepax Pharma Private Limited

Ceepax Pharma Private Limited, a active private limited company, was established on 16 April 2019 in Jabalpur, Madhya Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74994MP2019PTC048371. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Bhaskar Ghuratia (Director), Jitendra Kumar Namdeo (Director). Past directors included Jitendra Kumar Namdeo, Manali Namdeo. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H No. 12 Ukhari Road, Vivekanand Ward Ektanagar Jabalpur, Jabalpur, Madhya Pradesh, 482002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74994MP2019PTC048371

  • Registration Number

    048371

  • Incorporation Date

    16 April 2019

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** -29.47%
  • Profit Growth **** -23.85%
  • Ebitda **** 118.72%
  • Net Worth 20.76%
  • Total Assets -37.74%
Company report

Ceepax Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ceepax Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Ceepax Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Bhaskar Ghuratia Director 30 Mar 2021 Current
Jitendra Kumar Namdeo Director 04 Feb 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 10 Apr 2021 Past
Pramod Abcsdd Director 06 Feb 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ceepax Pharma.

Ceepax Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 29.47% decrease. The company also saw a substantial fall in profitability, with a 23.85% decrease in profit. The company's net worth Soared by an impressive increase of 20.76%.

Ceepax Pharma revenue growth over time
Ceepax Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -29.47%
*******
*******
*******
*******
Revenue from Operations
*******
 -29.45%
*******
*******
*******
*******
Total Assets
*******
 -37.74%
*******
*******
*******
*******
Profit or Loss
*******
 -23.85%
*******
*******
*******
*******
Net Worth
*******
 20.76%
*******
*******
*******
*******
EBITDA
*******
 118.72%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ceepax Pharma?

In 2020, Ceepax Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ceepax Pharma?

Unlock and access historical data on people associated with Ceepax Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ceepax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ceepax Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ceepax Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Ceepax Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Ceepax Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was completed.

  • Director Appointment

    Jitendra Kumar Namdeo was appointed as a Director was appointed as a Director on 04 Feb 2024 & has been associated with this company since 2 years 3 days . was recorded as a recent event.

  • Director Appointment

    Bhaskar Ghuratia was appointed as a Director was appointed as a Director on 30 Mar 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.

  • Company Incorporation

    The activity Ceepax Pharma Private Limited was registered on 16 Apr 2019 with Roc Gwalior & aged 6 years 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ceepax Pharma Private Limited?

The CIN of Ceepax Pharma Private Limited is U74994MP2019PTC048371.

Where is Ceepax Pharma Private Limited headquartered?

Ceepax Pharma Private Limited is headquartered at H No. 12 Ukhari Road, Vivekanand Ward Ektanagar Jabalpur, Jabalpur, Madhya Pradesh, 482002.

When was Ceepax Pharma Private Limited incorporated?

Ceepax Pharma Private Limited was incorporated on 16 April 2019.

Who are the current directors of Ceepax Pharma Private Limited?

The current directors of Ceepax Pharma Private Limited are

What is the primary industry of Ceepax Pharma Private Limited?

The primary industry of Ceepax Pharma Private Limited is Trade.

Is Ceepax Pharma Private Limited a listed company?

Ceepax Pharma Private Limited is unlisted.

What is the capital structure of Ceepax Pharma Private Limited?

The authorized capital of Ceepax Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available